According to a research report published by Spherical Insights and Consulting, The South Korea Docetaxel Market Size is anticipated to reach USD 69.29 Million by 2035, growing at a CAGR of 6.92% from 2025 to 2035. The growing use of targeted treatments, which are taking the place of conventional cytotoxic medicines in a number of cancer applications, is one factor limiting this. Additionally, the market demand is still being supported by the rising incidence of malignancies worldwide, especially those of the breast, lung, and prostate, for which docetaxel is still a common treatment option.